Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2005
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantationAttilio Olivieri, Moira Lucesole, Debora Capelli, et al.
Medicine|December 30, 2014
Fatal necrotizing angiotropic Epstein-Barr virus-negative large B-cell lymphoma: a case report with unusual clinicopathological features in-between lymphomatoid granulomatosis and T-cell/histiocyte-rich large B-cell lymphomaAttilio Olivieri, Elena Sabattini, Gaia Goteri, et al.
European Journal of Haematology|February 14, 2004
Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysisAttilio Olivieri, Marino Brunori, Debora Capelli, et al.
Blood|May 1, 2009
Imatinib for refractory chronic graft-versus-host disease with fibrotic featuresAttilio Olivieri, Franco Locatelli, Marco Zecca, et al.
Haematologica|January 22, 2002
Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatmentGiuliana Muti, Silvia Cantoni, Pierluigi Oreste, et al.
Cancers|December 11, 2022
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell LymphomaAlessia Bari, Chiara Gerardi, Eleonora Allocati, et al.
Frontiers in Oncology|September 28, 2023
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione UmanaCarla Minoia, Simonetta Viviani, Erica Silvestris, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 25, 2021
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life ExperienceMarina Moretti, Anna Marina Liberati, Luigi Rigacci, et al.
The Oncologist|April 26, 2012
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGAAttilio Olivieri, Guido Gini, Caterina Bocci, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 2014
Mobilization-driven postconsolidation therapy in elderly patients with acute myeloid leukemia: feasibility and efficacy of autologous stem cell transplantation versus low-dose gemtuzumab ozogamicinDebora Capelli, Martina Chiarucci, Antonella Poloni, et al.
Pageof 6